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Summary
Background: Incorrect usage of inhaler devices might have a major influence on the
clinical effectiveness of the delivered drug. This issue is poorly addressed in management
guidelines.
Methods: This article presents the results of a systematic literature review of studies
evaluating incorrect use of established dry powder inhalers (DPIs) by patients with asthma
or chronic obstructive pulmonary disease (COPD).
Results: Overall, we found that between 4% and 94% of patients, depending on the type of
inhaler and method of assessment, do not use their inhalers correctly. The most common
errors made included failure to exhale before actuation, failure to breath-hold after
ARTICLE IN PRESS
0954-6111/$ - see front matter & 2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.rmed.2007.11.003
Abbreviations: COPD, chronic obstructive pulmonary disease; DPI, dry powder inhaler; FEV1, forced expiratory volume in 1 s; pMDI,
pressurised metered dose inhaler..
Corresponding author at: Faculte´ de Me´decine, l’Institut du Thorax, Universite´ de Nantes, Nantes F-44000, France. Tel.: +33 2 40 41 29 57.
E-mail address: antoine.magnan@nantes.inserm.fr (A. Magnan).
Respiratory Medicine (2008) 102, 593–604
inhalation, incorrect positioning of the inhaler, incorrect rotation sequence, and failure to
execute a forceful and deep inhalation. Inefficient DPI technique may lead to insufficient
drug delivery and hence to insufficient lung deposition. As many as 25% of patients have
never received verbal inhaler technique instruction, and for those that do, the quality and
duration of instruction is not adequate and not reinforced by follow-up checks.
Conclusions: This review demonstrates that incorrect DPI technique with established DPIs
is common among patients with asthma and COPD, and suggests that poor inhalation
technique has detrimental consequences for clinical efficacy. Regular assessment and
reinforcement of correct inhalation technique are considered by health professionals and
caregivers to be an essential component of successful asthma management. Improvement
of asthma and COPD management could be achieved by new DPIs that are easy to use
correctly and are forgiving of poor inhalation technique, thus ensuring more successful
drug delivery.
& 2007 Elsevier Ltd. All rights reserved.
Introduction
Drugs for inhalation are the cornerstone of therapy in
obstructive lung disease.1,2 Inhalers are the principle
vehicles for the effective administration of asthma medica-
tion. They allow high lung deposition of the drug and
minimise systemic bioavailability, thus reducing possible
systemic adverse drug reactions.1,2 Pressurised metered
dose inhalers (pMDIs) and dry powder inhalers (DPIs) are the
devices most commonly used for drug delivery in the
treatment of asthma and chronic obstructive pulmonary
disease (COPD). DPIs, available since the 1970s, have been
developed to make inhalation simpler compared with pMDIs,
without the need to coordinate inhalation and actuation.3,4
DPIs are easier to use than pMDIs because they are breath-
activated, precluding the need for the patient to coordinate
actuation with inhalation, which can be particularly difficult
for some patients, including the elderly and children. This
assists with effective drug delivery to the lungs. In addition,
DPIs do not contain environmentally unfriendly propellants
and do not produce a cold sensation on inhalation. DPIs are
single or multiple dose inhalers that require loading before
inhalation as they are breath-actuated.1,3
The effectiveness of drugs for inhalation such as b2-
agonists, anticholinergic agents or corticosteroids, can be
influenced by many factors including age, sex and education
of the patient, duration of disease, type of inhaler used,
correct inhalation technique or use of several inhalers.5–9
Many elderly people have poor inhalation technique because
of medical problems such as arthritis, weakness or impaired
dexterity or vision.10 Correct inhalation technique plays a
vital role in effective asthma therapy alongside appropriate
drug usage.11 Incorrect usage of inhalers is a significant
problem for both asthma and COPD management because it
may result in diminished therapeutic effect, resulting in
poor control of symptoms and thereby insufficient disease
management.5–7,12,13 As a result, patients might receive
treatment, but without proper education and training in
correct inhalation technique, the therapeutic benefit is less
than optimal.
Technical features of inhaler devices have improved
constantly with time. However, the effectiveness in deliver-
ing drugs to the lungs depends on correctly performed
inhalation manoeuvres. In previous studies, it has been
shown that up to 85% of patients do not use their inhalers
correctly.9,14,15 Many inhalers, both pMDIs and DPIs, are
complicated to use, some requiring up to eight steps for a
correctly performed inhalation manoeuvre.16 To acquire the
skills required for using these medications, health profes-
sionals and patients must be adequately educated and
trained.17,18 Asthma management might improve with
devices which are easy to use correctly and have feedback
mechanisms confirming correct inhalation and assured drug
delivery.11
The objective of this review was to assess the incidence of
incorrect inhaler technique with established DPIs in patients
with asthma or COPD, to highlight the most common errors
observed in inhalation technique and to discuss implications
for clinical efficacy.
Materials and methods
Search strategy
The search strategy included primary and secondary
sources. MEDLINE (1966–2005) and EMBASE (1988–2005)
were used for the search in primary sources with the
following keywords: ‘mishandlings’, ‘errors’ or ‘incorrect
use’ in conjunction with the keyword ‘dry powder inhaler’.
The titles and abstracts of all articles produced by this
search were assessed for inclusion prior to retrieval of full
articles. All full articles were then subsequently reassessed
for inclusion, and only those dealing with inhaler technique
and meeting the inclusion criteria were included in the
analysis. There was no blinding of authors’ names or
institutions and no scoring system was used. We also
performed a manual search of the 15 most popular journals
(published between 2000 and 2005 by impact factor) on
respiratory diseases. This manual search included an
assessment of the title and abstract of all articles in these
journals. A search of secondary sources involved scanning all
references from the publications identified in the search of
the primary sources. Both searches were limited to human
studies.
Inclusion/exclusion criteria
Adult and paediatric studies were included in the analysis.
Only asthma and COPD studies addressing DPI usage were
ARTICLE IN PRESS
F. Lavorini et al.594
assessed for inclusion. Publications in English, Spanish,
French, Italian, German or Portuguese were included in
the analysis.
Commentaries, cost-analyses, surveys, letters to editors
and guidelines were excluded.
Results
The search of primary sources identified 47 articles on
incorrect use of DPIs in the management of asthma or COPD.
Secondary sources provided three more articles.
Misuse of DPIs
Studies in adult patients
DPIs are widely used in clinical practice; however, a number
of studies have shown that many patients do not use
currently established inhalers correctly, with the type of
inhaler contributing significantly to the rate of incorrect
usage (Table 1).5,9,10,12,14,16,19–39 Indeed between 4% and
94% of patients, depending on the type of inhaler and
method of assessment, do not use their DPIs correctly
(Table 1). Molimard et al.12 conducted an observational
study of 3811 patients with asthma or COPD. Patients were
treated for at least 1 month with drugs delivered through
pMDIs or DPIs, namely the Aerolizers (Novartis, USA),
Diskuss (GlaxoSmithKline, UK) or Turbuhalers (AstraZene-
ca, UK).12 Results showed that 76% of the patients using
pMDIs made at least one error compared to 49–55% of the
patients using DPIs, indicating differences in the use of
inhaler devices in ‘real life’ clinical practice and also
highlighting the fact that pMDIs are more difficult to use
than DPIs.12 Similarly, Hilton19 conducted a study to
evaluate the DPI inhalation technique of 422 patients from
34 clinical practices. In that study, technique scores were
rated as ‘good’, ‘adequate’ or ‘inadequate’. Overall, 25% of
the patients had an inadequate technique.19 More specifi-
cally, 4% of patients were unable to use the Turbuhalers
correctly compared with 21% and 19% for the Rotahalers
(GlaxoSmithKline, UK) and Diskhalers (GlaxoSmithKline,
UK), respectively.19 It is not surprising that such a high
proportion of patients were unable to use the Diskhalers
correctly as it is too complicated to use, requiring eight
steps to affect a correct inhalation. Additionally, with the
Diskhalers the drug blisters must be frequently changed,
the device must be cleaned before refilling and it provides
the patient with no feedback except for a sweet taste in the
mouth which may simply be indicative of high oropharyngeal
deposition. Patients frequently fail to pierce the drug
blisters top and bottom and may cover the air inlet holes
with their mouths whilst inhaling due to incorrect mouth-
piece positioning. In another study van der Palen et al.14
assessed inhaler technique of the Turbuhalers, Rotahalers
and Diskhalers. Errors were recorded against a predefined
list of steps for each inhaler. The results showed that 40% of
the patients were unable to perform all steps correctly.
Other studies have shown even higher rates of misuse
for the Turbuhalers ranging from 26% to 94%
(Table 1).5,9,12,21,22,25,26,29,30,33–35,39 Common mistakes
when using the Turbuhalers include failure to turn the base
fully in both directions and failure to keep the device
upright until loaded. In addition, the Turbuhalers has a
relatively high intrinsic resistance making it difficult to
generate a sufficient inspiratory flow in order to desagglo-
merate and release drug particles. This may be particularly
relevant for elderly patients, children and those patients
with severe airflow limitation.
Kesten et al.23 evaluated use of the Diskhalers in a 2-
week study with 4529 patients with reversible obstructive
airway disease who required b2-agonist treatment. Although
the majority of the patients (98.5%) used the Diskhalers
correctly after instructions at the beginning of the study,
incorrect use was noted at the end of the trial mandating
the need and importance for regular instruction.23 The
overall results from the study showed that 10.2% of the
elderly patients and 3.2% of the patients in all other age
groups combined did not use the Diskhalers correctly.23 In
the present review, we found that as many as 68% of patients
misuse their Diskhalers and as many as 67% misuse their
Rotahalers.16,21 Other DPIs fare slightly better with up to
57% of patients unable to use their Diskuss cor-
rectly.12,29,34,36,39 The mouthpiece of the Diskuss has
frequently been cited as user-unfriendly; in addition, due
to its drug blister design, incomplete emptying of the
metered dose may occur.40 We found evidence that 11% of
patients were unable to use the Cyclohalers (Pharmachem-
ie, the Netherlands) correctly,5 12–17% incorrectly used the
Aerolizers12,32,34 and up to 55% misused the Easyhalers
(Table 1).37,39 The Easyhalers should be shaked before use
and the active ingredient may escape if patients exhale into
the system.40 Since the Aerolizers, like the Diskuss, may
suffer from incomplete emptying of the metered dose, the
inhalation manoeuvre could be repeated with an increased
risk of overdosing.
Studies in children and adolescents with asthma
In children, as well as in adults, correct use of inhalers is
vital for the management of asthma and other respiratory
diseases. Most children do not, however, use their inhalers
correctly and the ability to correctly use an inhaler
positively correlates with age. Studies have shown that
children experience the same problems as adults in the
correct use of inhalers.6,7,41–43 Table 2 shows percentages of
children who did not perform the inhalation technique
correctly in a number of studies using different DPIs.
Pedersen et al.6 conducted a study for 4 months to assess
the correct use of inhalers in 256 children aged 4–16 years.
They showed that 54% of these children were unable to use
the Rotahalers correctly.6
Children fared no better with the Turbuhalers. The
clinical efficacy of terbutaline sulphate delivered through
the Turbuhalers was evaluated in 59 children aged between
3 and 6 years by scoring the clinical state of asthma before
and 10min after drug inhalation.7 Inhalation technique was
evaluated by using a graded score and the clinical response
using three variables: inspiratory wheezing, expiratory
wheezing and prolonged expiration.7 The results showed
that 57% of the 4-year-old children, 33% of the 5-year-old
children and 20% of the 6-year-old children did not use the
inhaler correctly; indeed, all 3-year-old children were
unable to perform the inhalation technique correctly.7 De
Boeck et al.41 confirmed this age-dependent relationship
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Table 1 Characteristics of studies involving adult patients with asthma and COPD included in the review.
Study No. of
patients
Type of inhaler % of patients with incorrect
inhalation technique
Hesselink et al.5 558 Diskhalers 4
Cyclohalers 11
Rotahalers 37
Turbuhalers 31
van der Palen et al.9 321 Turbuhalers, Diskhalers, Cyclohalers, Ingelheim
inhalers, Rotahalers
29
Franks et al.10 80 Multidose DPI 25 errors
Capsule DPI 6 errors
Molimard et al.12 3811 Aerolizers 54
Diskuss/Accuhalers 49
Turbuhalers 54
van der Palen et al.14 152 Turbuhalers, Diskhalers, Rotahalers 40
van Beerendonk et al.16 316 Diskhalers 49
Rotahalers 67
Ingelheim inhalers 36
Hilton19 422 Turbuhalers 4
Rotahalers 21
Diskhalers 19
Dompeling et al.20 50 Rotahalers 27
Nimmo et al.21 20 Diskhalers 68y
Turbuhalers 94y
van der Palen et al.22 123 Diskhalers 14
Rotahalers 65
Turbuhalers 54
Kesten et al.23 4529 Diskhalers 10 in the elderly patients 3
of all other age groups
combined
Olaguibel Rivera et al.24 296 DPIs 30
van der Palen et al.25 50 Diskuss/Accuhalers 8
Turbuhalers 26
Campos et al.26 150 Turbuhalers 42
Cimas et al.27 34 Turbuhalers 26
Carrion-Valero et al.28 554 Turbuhalers 59
Serra-Battles et al.29 169 Diskuss 30
Turbuhalers 31
Estarriol et al.30 186 Turbuhalers 68
Aiolfi et al.31 71 Pulvinals 18
Cinti et al.32 158 Aerolizers 17
Canessa et al.33 309 Turbuhalers 48
Girodet et al.34 984 Turbuhalers 38
Aerolizers 12
Diskuss 13
Botting et al.35 188 Turbuhalers, Diskhalers 33
Kamin et al.36 1423 Turbuhalers 39
Diskuss 17
Giner et al.37 30 Diskuss/Accuhalers 0
Easyhalers 0
Turbuhalers 0
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showing that only 4% of children over 8 years were unable to
use the Turbuhalers compared with 45% of children aged
between 5 and 8 years.
A study by Kamps et al.43 showed that up to 80% of
children did not use the inhaler correctly when the
instructor demonstrated the technique, but that education
and training improved inhalation technique in these children
and adolescents.43 Overall, analysis showed that repetition
of the instructions was significantly correlated with correct
inhalation technique (po0.0001) irrespective of the type of
inhaler used.43 In a similar study Gracia-Antequera and
Morales Suarez-Varela42 assessed the inhalation technique of
255 children and adolescents using DPIs and pMDIs before
and after training. The results showed an increased (76%)
frequency of correct use after training compared with
baseline (47%).42 However, it is worth noting that a
significant number of patients (24.5%) were still not able
to use their devices correctly even after instruction.42
Specific errors in DPI technique
The main determinants of incorrect inhaler use are
compliance, type of inhaler, use of several inhalers,
patients’ characteristics and low emotional quality of life.5,9
It has been shown that patients using pMDIs make more
errors than users of other types of inhalers.5 Children newly
referred to asthma clinics were found to make more errors
with inhalers, possibly because of lack of re-assessment and
re-enforcement of their technique.43
Incorrect use of inhalers can lead to detrimental effects
on asthma management44; nevertheless, studies have shown
that patients do not comply with the individual steps of the
inhalation maneouvre.2 Table 3 summarises studies involving
adult and paediatric patients with asthma exhibiting specific
errors in inhalation technique with established DPIs. The
most frequently observed error was failure to exhale before
inhaling through their DPI device (12–77%). A comfortable
exhalation to, or just below functional residual capacity is
an accepted alternative to exhalation to residual volume,
being less likely to provoke cough while still retaining
efficacy.45 Other specific inhalation technique errors in
order of frequency included failure to breath hold after
inhalation (0–73%); failure to forcefully and deeply inhale
through the device (0–48%); incorrect dose metering
(1–46%); incorrect rotation sequence (i.e. rotation of grip
until ‘click’ is heard, 0–45%); incorrect inhaler position
(0–44%); failure to breathe out slowly after inhalation
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Table 1 (continued )
Study No. of
patients
Type of inhaler % of patients with incorrect
inhalation technique
Ho et al.38 500 Various breath-activated devices 28
Ro¨nmark et al.39 326 Easyhalers 55
Diskuss/Accuhalers 57
Turbuhalers 49
Number of errors made by patients; DPI, dry powder inhaler; pMDI, pressurized metered dose inhaler.
yFollowing written instruction alone.
Table 2 Characteristics of studies involving paediatric asthma patients included in the review.
Study No. of
patients
Type of inhaler % of children with incorrect
inhalation technique
Pedersen et al.6 256 Rotahalers 54
Goren et al.7 59 Turbuhalers 3-year old: 100
4-year old: 57
5-year old: 33
6-year old: 20
De Boeck et al.41 161 Turbuhalers 48 years: 4
5–8 years: 45
Gracia-Antequera and
Morales Suarez-
Varela42
255 DPI 39
Kamps et al.43 200 Turbuhalers, Diskhalers, Diskuss/
Accuhalers
22
DPI, dry powder inhaler.
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Table 3 Characteristics of studies performed in patients with asthma and COPD exhibiting specific errors in dry powder inhaler technique.
Study Type of
inhaler
Type of error
Incorrect dose
metering
Incorrect
inhaler
positioning
Incorrect
rotation
sequence
No exhalation
before
activation
Incorrect
mouthpiece
positioning
No forceful
and deep
inhalation
No breath
hold
Failure to
breathe out
slowly
Hesselink et al.5
(n ¼ 558)
Diskhalers 3 – – – – 2 – –
Cyclohalers 1 9 – – – 0 – –
Rotahalers – 34 3 – – 1 – –
Turbuhalers – 29 2 – – 2 – –
Pedersen et al.6
(n ¼ 256)
Rotahalers 46 – – 62 – 41 49 –
van der Palen et al.9
(n ¼ 321)
Accuhalers – 0 – 25 0 – 0 –
Cyclohalers 0 0 – 40 0 0 30 –
Diskhalers 2 – 10 28 7 9 16 –
Ingelheim
inhalers
0 – – 12 0 0 0 –
Rotahalers 2 32 2 53 4 7 34 –
Turbuhalers – 29 2 38 2 2 17 –
Molimard et al.12
(n ¼ 3811)
Aerolizers 1 – – 33 – – 29 –
Diskuss – – – 30 – – 26 –
Turbuhalers – 18 15 30 – – 25 –
van der Palen et al.14
(n ¼ 152)
Diskhalers 4 – – 44 4 0 37 19
Rotahalers 4 37 0 66 21 10 54 21
Turbuhalers – 31 0 66 28 6 41 16
van Beerendonk et al.16
(n ¼ 316)
Different
types of DPI
14 7 – 66 4 19 53 –
Dompeling et al.20
(n ¼ 50)
Rotahalers – 32 0 68 – 2 44 –
Diskhalers 32 0 – 58 26 26 32 32
F.
Lavorini
et
al.
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Nimmo et al.21
(n ¼ 20)
Turbuhalers 38 44 44 44 19 25 31 31
van der Palen et al.22
(n ¼ 123)
Diskhalers – 0 – 64 29 14 50 43
Rotahalers 14 31 45 71 20 22 73 35
Turbuhalers 15 31 38 77 35 19 61 15
Kesten et al.23
(n ¼ 4529)
Diskhalers 1.0 – – – – 1.0 – –
Olaguibel Rivera
et al.24 (n ¼ 296)
DPIs 14 – – – – 10 32 –
van der Palen et al.25
(n ¼ 50)
Diskuss 8 – 40 0 0 6 2
Turbuhalers 14 12 – 38 0 0 6 2
Campos et al.26
(n ¼ 150)
Turbuhalers – 10 10 – 5 10 – –
Estarriol et al.30
(n ¼ 186)
Turbuhalers 23 18 – 58 13 48 68 –
Cinti et al.32 (n ¼ 158) Aerolizers – – – – 6 11 – –
Canessa et al.33
(n ¼ 309)
Turbuhalers 15 – – 13 – 15 – –
Ghirodet et al.34
(n ¼ 984)
Aerolizers 5 – – 40 – – 33 –
Autohalers – – – 28 – – 37 –
Diskuss – – – 40 9 – 36 –
Turbuhalers – 22 13 37 – – 32 –
De Angelis et al.52
(n ¼ 358)
Diskuss – – – 18 – – –
For each considered study, values represent the percentage of patients showing specific errors in the use of dry powder inhaler (DPI).
After written instruction only.
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(2–43%); and incorrect mouthpiece position (i.e. not
positioning the mouthpiece correctly between the lips,
0–35%).
The three most frequent errors made by patients for each
DPI are reported in Table 4. Irrespective of the device
employed, the most frequent error was failure to exhale
before inhaling through their DPI (Table 4). This is
important, as without an adequate exhalation patients
may be unable to inhale forcefully and deeply enough
through their DPI in order to ensure deposition of drug into
the lungs. The second most frequent error for most devices
was failure of patients to hold their breath after they had
completed inhaling through the device. The exceptions to
this finding were with the Diskhalers and the Turbuhalers
where the second most frequent error exhibited by patients
was due to incorrectly performed metering of the dose and
incorrect inhaler positioning, respectively. The third most
frequent error varied according to device. For the Rotaha-
lers and Cyclohalers, it was incorrect inhaler position, for
both the Diskhalers and Turbuhalers it was failure by
patients to breath hold; for the Diskuss and Aerolizers it
was incorrect dose metering; and for the Autohalers it was
incorrect mouthpiece positioning (Table 4).
Whilst all inhaler errors have the potential to limit clinical
efficacy, some errors are more important than others in this
respect. Molimard et al.12 defined lack of exhalation before
inhalation and failure to breath-hold post-inhalation as
device-independent errors.12 Inhaler errors were defined as
critical if they could have substantially affected dose
delivery to the lung. Critical errors for all DPIs included
lack of inhalation through the mouthpiece and blowing into
the device before inhalation.12 However, it should be noted
that exhaling into a DPI would be of greater significance with
bulk reservoir devices such as the Turbuhalers, but less so
for the Diskuss in which unit doses are sealed until priming.
Device-specific critical errors were lack of capsule insertion
and lack of two-button press and release for the Aerolizers,
not raising the lever to the vertical position whilst using the
Autohalers and not sliding the lever as far as possible whilst
using the Diskuss.12 Critical errors likely to affect clinical
efficacy whilst using the Turbuhalers included not holding
the inhaler in the upright position for grip rotation and also
incorrect rotation sequence.12 Generally, the most impor-
tant error in the use of a DPI is failure to achieve a forceful
and rapid inspiratory flow at the beginning of inspiration.46
The consequences of this type of inhalation error are dealt
with in the discussion section.
Effect of DPI technique on clinical efficacy of
medications
It is reasonable to hypothesise that to be effective inhaled
therapies must be delivered to local sites of action within
the lung in sufficient quantities. Of note, few studies have
addressed the clinical impact of poor inhaler. For example,
Molimard et al.12 showed that overall treatment efficacy
was compromised in about 12% of patients using the
Aerolizers or the Diskuss, compared to 32% and 28% of
the patients using the Turbuhalers and pMDIs, respectively.
Interestingly, overestimation of good inhalation by general
practitioners (GPs) was maximal for the Turbuhalers (24%)
and lowest for the Diskuss (9%).12 Only 70–80% of the
patients, according to the GPs, inhaled the drug dose
through their DPIs correctly.12 Patients who improved their
inhalation technique showed significant reduction in the
frequencies of total and nocturnal asthma symptoms, as
well as b2-agonist usage.
13
Hesselink et al.5 showed that about 24% of patients using
DPIs made at least one critical error causing detrimental
effects on effective asthma management. Although not
statistically significant, chronic cough, wheezing and low
total scores in health-related quality of life questionnaire
were associated with incorrect inhalation technique. In
addition, Pedersen et al.6 showed that in children using the
Rotahalers, there was a statistically significant negative
correlation between the numbers of errors and the increase
in forced expiratory volume in 1 s (FEV1). Coordination
problems seemed to be more important than other errors in
influencing lung function.6 Others have shown that efficient
DPI technique is associated with improved clinical out-
comes.7
Discussion
In this systematic review, we have analysed studies aimed at
evaluating the quality of inhalation technique with well-
established DPIs in both adult and paediatric patients with
asthma or COPD. We found that a large proportion of
patients do not use established DPIs correctly. Furthermore,
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Table 4 Most frequent errors by device made by asthma or COPD patients.
Inhaler 1st most frequent error 2nd most frequent error 3rd most frequent error
Rotahalers No exhalation before inhalation No breath hold Incorrect inhaler position
Diskhalers No exhalation before inhalation Incorrect dose metering No breath hold
Turbuhalers No exhalation before inhalation Incorrect inhaler position No breath hold
Diskuss No exhalation before inhalation No breath hold Incorrect dose metering
Cyclohalers No exhalation before inhalation No breath hold Incorrect inhaler position
Aerolizers No exhalation before inhalation No breath hold Incorrect dose metering
Ingelheim inhalers No exhalation before inhalation
Autohalers No exhalation before inhalation No breath hold Incorrect mouthpiece positioning
Only one study.
F. Lavorini et al.600
common errors made by a significant proportion of patients
were failure to exhale before inhaling through the device,
incorrect positioning of the inhaler, incorrect loading and
positioning of the device, failure to forcefully and
deeply inhale through the device and patients’ failure to
hold their breathe hold after inhalation. All these errors
may lead to insufficient drug delivery, which adversely
influences drug efficacy and may contribute to inadequate
control of asthma and COPD. A further important point
emerging from this review is that the problem of incorrect
use of DPIs is seriously underestimated by healthcare
professionals.
One of the most important factor for the correct use of
DPIs is the generation of a forceful and deep inhalation
through the device.3 However, many patients are unable to
generate sufficient inspiratory airflow to use their DPIs
correctly, resulting in poor drug release and low pulmonary
deposition.3 This is particularly true for elderly patients,
children and those with severe airflow limitation.3 The
particle size of drug generated by DPIs is also critical for
therapy success, as the size of the drug particle dictates
deposition patterns within the lung.3 With DPIs, the
respirable particle fraction and consequently drug deposi-
tion are dependent on inspiratory flow rate achieved by the
patient. This dependency has been clearly shown with the
Turbuhalers.46 In fact, it has been shown that, if patients
inhale maximally through the Turbuhalers at the start of the
inhalation manoeuvre, most of the emitted particles have a
diameter between 1 and 6mm and so would be deposited in
the lung. If, however, the patient starts to inhale slowly at
first and gradually increases the force of their inhalation
effort, then the diameter sizes of the emitted particles
increase substantially resulting in higher drug deposition in
the mouth and oropharynx.46 Furthermore, the clinical
significance of inhalation speed seems to vary with particle
size.47 While small particles (i.e. 1.5 mm diameter) have a
comparable effect on FEV1 regardless of inhalation speed,
larger particles (i.e. 3–6 mm diameter) exert a greater
bronchodilator effect when inhaled at a slower speed.47 The
situation is further complicated by the fact that the ideal
particle size can vary depending on the inhaled active drug.
For example, inhaled b2-agonists should be ideally separated
into relatively large aerosol particles (i.e. 43–6 mm) which
are mainly deposited in the large airways where they exert
their greatest effect whist minimising systemic effects.47 In
contrast, it is likely that inhaled corticosteroids would exert
greatest effect if delivered as smaller particles which can
reach the peripheral lung regions and corresponding sites of
inflammation.
In the present systematic review, every effort was made
to conduct a comprehensive literature search of both
primary and secondary sources. MEDLINE (1966–2005) and
EMBASE (1988–2005) were thoroughly searched, and a
manual search of the 15 most popular respiratory journals
was conducted assessing the titles and abstracts of all
articles in these journals and scanning all references from
the publications identified in the search of the primary
sources. Using these search strategies, 50 articles were
identified which provided information on use and misuse of
DPIs in the clinical setting. However, our literature search
could be not exhaustive as it did not include a search of
Science Direct, PubMed or Scopus databases. In addition,
the search term ‘dry powder inhaler’ may not have been
sufficient to pick up all relevant papers.
By their nature most studies examining inhalation
technique are subjective by design, as they do visual
assessment of patient inhaler technique measured against
a pre-defined checklist of device-specific correct steps. This
type of study design raises the possibility of observer bias
and the likelihood of poor intra-observer repeatability. To
reduce the subjective nature of assessment of patients’
inhalation technique, Kamin et al.36 used a new computer-
based device to evaluate the inhalation technique of
patients using the Turbuhalers, Autohalers or Diskuss.
Interestingly, the results of that objective study mirrored
the results of the subjective studies.
Inability of patients to correctly use their inhaler device
may be a direct consequence of insufficient or poor inhaler
technique instruction. Training apparently results in a more
efficient use of established DPIs,7,48,49 but these training
sessions must be repeated, and the results checked at
regular intervals. The quality of the initial instruction is of
paramount importance for the outcome of inhalation
therapy.6,50 Written instruction alone is inadequate in
teaching correct inhalation technique. Verbal instruction
and technique assessment and reassessment are essential
for patients to achieve proper technique.21 This necessitates
dedicated resources, which may be a problem in the current
cost-containment environment. As many as 25% of patients
have never received verbal inhaler technique instruc-
tion.21,51 Those who have received some inhaler instruction
reveal that this is almost always of less than 10min
duration,33,52 with no follow-up assessment in 45% of
cases.33 Follow-up checks on inhaler technique are impor-
tant when one considers that as early as 3 days after
successful instruction, more than one-third of patients no
longer use their DPI correctly.21 Interestingly, patients who
receive inhalation instructions at least once more after the
initial instruction have better inhalation technique compared
with those who received a single inhalation instruction at the
time of prescription.41 Training in correct inhaler use rather
than instructor demonstration appears to be important.42,43
Training devices to optimise patients’ breathing whilst using a
DPI have now been developed. These devices are easy to use
and measure patient’s inspiratory flow, so that inhalation
technique can be learned quickly, even by children, and
checked by a doctor or practice nurse. One such training
device, the Mag-Flos (Fyne dynamics Ltd., UK), uses a
magnetic flow sensor and is attached by means of an adaptor
to the inhaler or training placebo.53 When a patient inhales
properly, the magnetic flow sensor is activated, switching on
a battery powered green LED that can be seen by the patient.
If the patient inhales too strongly or too softly the light goes
out.53 The In-Check DialTM (Clement Clarke International
Ltd., UK) is another training device which can be used to train
patients to inhale correctly through DPIs and can be used to
identify the most suitable inhaler for each individual.54 It is a
hand-held inspiratory flow measurement device with a dial
top which can accurately simulate the resistance of a wide
variety of DPIs currently on the market.54 Although these
training devices are useful for training patients how to inhale
through a device, they obviously do not teach patients how to
hold, prime and position their inhaler device for optimum
benefit.
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The incorrect use of DPIs is not confined to patients.
Healthcare professionals typically use DPIs poorly.17 Demon-
stration skills and knowledge scores of medical personnel for
the use of both the Turbuhalers and Diskuss have been
shown to be substantially lower than that for a pMDI.53
Medical personnel responsible for teaching the correct use
of inhalation devices are therefore lacking in basic knowl-
edge and user skills. This probably contributes to patients’
poor technique when using these devices. To ensure correct
advice is provided to patients, healthcare professionals
should be well versed in how to operate the various devices
used by their patients and they should have access to
demonstration devices. Education of healthcare profes-
sionals significantly improves their inhaler technique.18 In
addition, regular ongoing training should be provided to
ensure that clinicians retain these skills.
In conclusion, although DPIs are thought to be easier to
use than pMDIs, many patients with asthma or COPD still are
not confident using them correctly. Regular assessment and
reinforcement of correct inhalation technique by health
professionals and caregivers are essential to improve disease
management. The ideal inhalation device should be refill-
able, versatile enough to be used potentially for any inhaled
medication for asthma and COPD, and immune to dampening
by breathing back into the device. Furthermore, it should
provide visual and auditory feedback and a dose counter
which resets after a correct inhalation manoeuvre confirm-
ing not only that inhalation has occurred, but also that an
inhalation is sufficient to deliver the drug. Such a device,
with feedback mechanisms which guide patients through the
correct inhalation manoeuvre, may improve inhalation
technique and, thereby, asthma and COPD management.
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